Oklahoma University-Stephenson Cancer Center

Oklahoma City, Oklahoma 73104

2 studies enrolling now · 9 studies all time

What they study most

Advanced Solid Tumors, Breast Cancer, CLL, Cancer, Colorectal Cancer, DLBCL, Endometrial Cancer, Endometrioid Endometrial Cancer, Endometrioid Tumor, Follicular Lymphoma, Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC)

Studies at this site

• A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors — Recruiting now
• Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC — Recruiting now
• Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer — Recruiting now
• INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC — Running, not enrolling
• Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial — Running, not enrolling
• A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors — Stopped early
• A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors — Completed
• AO-176 in Multiple Solid Tumor Malignancies — Completed
• Study of LM-102 in Subjects in Advanced Tumors — Stopped early